Roche Holding AG EPS - Earnings per Share 2012-2025 | RHHBY

Roche Holding AG earnings per share (EPS) for the twelve months ending December 31, 2025 was $0.00, a 0% increase year-over-year.

  • Roche Holding AG EPS for the quarter ending December 31, 2025 was $0.00, a 0% increase year-over-year.
  • Roche Holding AG 2025 annual EPS was $2.42, a 65.3% increase from 2024.
  • Roche Holding AG 2024 annual EPS was $1.46, a 26.54% decline from 2023.
  • Roche Holding AG 2023 annual EPS was $1.99, a 0.99% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Roche Holding AG EPS - Earnings per Share 2012-2025 | RHHBY

  • Roche Holding AG EPS for the quarter ending December 31, 2025 was $0.00, a 0% increase year-over-year.
  • Roche Holding AG 2025 annual EPS was $2.42, a 65.3% increase from 2024.
  • Roche Holding AG 2024 annual EPS was $1.46, a 26.54% decline from 2023.
  • Roche Holding AG 2023 annual EPS was $1.99, a 0.99% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B